VIB

VIB and Surface Oncology Announce Publication in Cell Reports Revealing IL-27 Structure and the Mechanism of Action for SRF388

Retrieved on: 
Wednesday, October 19, 2022
CD73, Neoplasm, Plant, University, Novartis, Cell Reports, Engineering, Veterinary medicine, Hasselt University, Life Sciences Institute, Ghent University, Department, Inflammation Research, VIB, GLOBE, Surface, KU Leuven, FDA, IL-27, Animal, Employment, Structural biology, Research, University of Antwerp, University of Pennsylvania School of Veterinary Medicine, Unit, Inflammation, Life, Cytokine, Patient, Biotechnology, Professor, Kidney, Partnership, Orphan drug, Tumor microenvironment, PVRIG, Vrije Universiteit Brussel, GlaxoSmithKline, Â, CD39, CCR8, Liver, Fast Track, Entrepreneurship, Interleukin, Pharmaceutical industry, Coffee, Vaccine

FLANDERS, Belgium and CAMBRIDGE, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) -- VIB, Flanders’ leading life sciences institute, and Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced jointly the publication of a study entitled, “Structural basis of activation and antagonism of receptor signaling mediated by interleukin-27: Cell Reports,” in Cell Reports, a leading scientific journal. The study was a collaborative research effort between the Unit for Structural Biology at the VIB-University of Ghent Center for Inflammation Research and Surface Oncology.

Key Points: 
  • The study was a collaborative research effort between the Unit for Structural Biology at the VIB-University of Ghent Center for Inflammation Research and Surface Oncology.
  • can be found in the October 18 issue of Cell Reports [VOLUME 41, ISSUE 3, 111490, https://www.cell.com/cell-reports/fulltext/S2211-1247(22)01340-7 .
  • Furthermore, Surface Oncology has identified a potential biomarker associated with IL-27 that may be useful in helping to identify patients most likely to respond to SRF388.
  • VIB is an independent research institute where some 1,800 top scientists from Belgium and abroad conduct pioneering basic research.

ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy and Appoints Dr. Jeanne Bolger as Chair of the Board of Directors

Retrieved on: 
Thursday, October 20, 2022
Union, Omicron, Therapy, Disease, Government, Fever Dream, Population, Vaccine, GMP, Severe acute respiratory syndrome coronavirus 2, Antibody, Commercial, Climate, Epitope, Medicine, Research, Llama, VHH, Dengue fever, Investment, Coronavirus, Technology, Infection, Solution, Johnson & Johnson, Company, Public health, Immunodeficiency, COVID-19, GlaxoSmithKline, Board, Trinity College Dublin, CEO, Business development, University College Dublin, Chair, VIB, Royal Academy of Arts, Terra Venture Partners, Vaccination, Director, SARS, EU, Trinity College, Global health, Leadership, Pharmaceutical industry, Noshaq

GHENT, Belgium, Oct. 20, 2022 /PRNewswire/ -- ExeVir is developing robust therapies providing broad protection against infectious diseases, including coronaviruses. The company has identified high potential candidates harnessing its unique, modular Llama-derived antibody (VHH) technology platform to generate multi-specific antibodies for prophylaxis and treatment against COVID-19. ExeVir is evaluating highly potent heavy chain based antibodies that are unique in targeting both S1 and S2 subunits of the coronavirus spike protein via highly conserved epitopes. Multiple high potential binders offer the potential of heterodimer binders to the spike protein in a molecule or a cocktail.

Key Points: 
  • ExeVir aims to select a final preclinical development candidate before year end 2022 ready for further development in 2023.
  • ExeVir is pleased to announce today the appointment of Dr Jeanne Bolger as Chair to the Board of Directors.
  • We are extremely pleased to welcome Jeanne as Chair of the Board at such a pivotal time for the Company.
  • In addition to its SARS-CoV-2 programs ExeVir has initiated research in dengue, a disease which is rapidly and progressively expanding.

ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy and Appoints Dr. Jeanne Bolger as Chair of the Board of Directors

Retrieved on: 
Thursday, October 20, 2022
Union, Omicron, Therapy, Disease, Government, Fever Dream, Population, Vaccine, GMP, Severe acute respiratory syndrome coronavirus 2, Antibody, Commercial, Climate, Epitope, Medicine, Research, Llama, VHH, Dengue fever, Investment, Coronavirus, Technology, Infection, Solution, Johnson & Johnson, Company, Public health, Immunodeficiency, COVID-19, GlaxoSmithKline, Board, Trinity College Dublin, CEO, Business development, University College Dublin, Chair, VIB, Royal Academy of Arts, Terra Venture Partners, Vaccination, Director, SARS, EU, Trinity College, Global health, Leadership, Pharmaceutical industry, Noshaq

GHENT, Belgium, Oct. 20, 2022 /PRNewswire/ -- ExeVir is developing robust therapies providing broad protection against infectious diseases, including coronaviruses. The company has identified high potential candidates harnessing its unique, modular Llama-derived antibody (VHH) technology platform to generate multi-specific antibodies for prophylaxis and treatment against COVID-19. ExeVir is evaluating highly potent heavy chain based antibodies that are unique in targeting both S1 and S2 subunits of the coronavirus spike protein via highly conserved epitopes. Multiple high potential binders offer the potential of heterodimer binders to the spike protein in a molecule or a cocktail.

Key Points: 
  • ExeVir aims to select a final preclinical development candidate before year end 2022 ready for further development in 2023.
  • ExeVir is pleased to announce today the appointment of Dr Jeanne Bolger as Chair to the Board of Directors.
  • We are extremely pleased to welcome Jeanne as Chair of the Board at such a pivotal time for the Company.
  • In addition to its SARS-CoV-2 programs ExeVir has initiated research in dengue, a disease which is rapidly and progressively expanding.

EQS-News: DIC Asset AG creates shopping experience with feel-good factor: “TO HUUS” shopping centre in Mönchengladbach-Rheydt

Retrieved on: 
Thursday, September 22, 2022
People, SDAX, Creativity, DIC, VIB, ISIN, Social media, Rheydt, Tenant, AG, Retail, Real estate

DIC Asset AG creates shopping experience with feel-good factor:TO HUUS shopping centre in Mnchengladbach-Rheydt

Key Points: 
  • DIC Asset AG creates shopping experience with feel-good factor:TO HUUS shopping centre in Mnchengladbach-Rheydt
    The issuer is solely responsible for the content of this announcement.
  • DIC Asset AG creates shopping experience with feel-good factor: TO HUUS shopping centre in Mnchengladbach-Rheydt
    Frankfurt am Main, 22 September 2022.
  • DIC Asset AG (DIC), ISIN: DE000A1X3XX4, one of Germanys leading listed property companies, completed its comprehensive modernisation works at the TO HUUS retail property on Stresemannstrasse in the centre of the Rheydt district of Mnchengladbach today.
  • Our approach to the TO HUUS shopping centre demonstrates that we are well aware of this fact and know how to proceed accordingly.

EQS-News: DIC Asset AG renews leases for about 11,000 sqm of retail space at “Neustadt Centrum” in Halle

Retrieved on: 
Monday, September 19, 2022
Investment, Frankfurt, EPRA, SDAX, CEO, LED, Â, DIC, VIB, ISIN, AG, Lease, Real estate

DIC Asset AG (DIC), ISIN: DE000A1X3XX4, one of Germanys leading listed property companies, just signed long-term lease renewals for about 11,000sqm of retail space at the Neustadt Centrum retail property, which it holds in its proprietary portfolio.

Key Points: 
  • DIC Asset AG (DIC), ISIN: DE000A1X3XX4, one of Germanys leading listed property companies, just signed long-term lease renewals for about 11,000sqm of retail space at the Neustadt Centrum retail property, which it holds in its proprietary portfolio.
  • With anchor tenant mein real (formerly real), DIC signed a lease agreement for about 10,200sqm of retail space that will end in 2036.
  • The two companies agreed to invest significant amounts in the modernisation of the retail unit.
  • On average, Neustadt Centrum is frequented by around 12,000 visitors from the catchment area every day.

DGAP-News: DIC Asset AG takes double gold at this year’s EPRA award

Retrieved on: 
Monday, September 12, 2022
EPRA, Carbon, ISIN, ESG, Trust, AG, Intention, Industry, Gold, CEO, SDAX, Annual report, VIB, European Public Real Estate Association, Frankfurt, DIC, Communication, Real estate

Annual report wins gold in repeat performance: commended for transparency and clarity of communication

Key Points: 
  • Annual report wins gold in repeat performance: commended for transparency and clarity of communication
    First-time gold score for sustainability report: clear-cut sustainability targets communicated
    Frankfurt am Main, 12 September 2022.
  • DIC Asset AG (DIC), ISIN: DE000A1X3XX4, one of Germanys leading listed property companies, was honoured by the European Public Real Estate Association (EPRA) as it received a gold award both for its current financial and ESG reporting in 2021.
  • We are operating within an industry that puts a premium on winning and retaining the trust of tenants and investors.
  • IR/PR Contact DIC Asset AG:

DGAP-News: DIC Asset AG: “Uptown Tower” and “Campus C” meet Green Building standard

Retrieved on: 
Tuesday, September 6, 2022
ISIN, CEO, SDAX, AG, DIC, ESG, Frankfurt, New Work, Industry, Environment, VIB, Security (finance), Property insurance, Renting, Real estate

A few days ago, DIC Asset AG (DIC), ISIN: DE000A1X3XX4, one of Germanys leading listed property companies, received green building certificates for the Uptown Tower and CampusC, two properties the company acquired in Munich last year.

Key Points: 
  • A few days ago, DIC Asset AG (DIC), ISIN: DE000A1X3XX4, one of Germanys leading listed property companies, received green building certificates for the Uptown Tower and CampusC, two properties the company acquired in Munich last year.
  • The Uptown Tower was placed with a group of institutional investors near the end of 2021.
  • When it comes to responsibility, you can rely on DIC, commented Sonja Wrntges, CEO of DIC.
  • More details on the properties:
    With its 37 storeys, the Uptown Tower is considered the highest building in Bavaria.

DGAP-News: VIB Vermögen AG: Ordinary General Meeting approves dividend of EUR 0.85 per share

Retrieved on: 
Wednesday, August 31, 2022
AG, BDO, Financial Oversight and Management Board for Puerto Rico, DIC, Supervisory board, Acquisition, VIB, EUR, Security (finance), Holding company, Pension fund

The joint proposal by the Management Board and the Supervisory Board to distribute a dividend of EUR 0.85 per no-par value share with dividend entitlement, either in cash or in shares, received a majority of 99.97%.

Key Points: 
  • The joint proposal by the Management Board and the Supervisory Board to distribute a dividend of EUR 0.85 per no-par value share with dividend entitlement, either in cash or in shares, received a majority of 99.97%.
  • This means that the dividend has increased by almost twelve percent compared to the previous year.
  • All members of the Supervisory Board during this period were also discharged with a large majority.
  • In the subsequent constituent meeting of the Supervisory Board, Mr. Ludwig Schlosser was confirmed as Chairman of the Supervisory Board and Mr. Jrgen Wittmann as Deputy Chairman of the Supervisory Board.

KU Leuven spin-off AstriVax raises € 30 million seed capital to build vaccine platform

Retrieved on: 
Thursday, August 25, 2022
Energy, CEO, KU Leuven, Technology, BEL20, Private banking, Virus, Medtech, Vaccine, Flanders, Care, Euronext, Patient, BNP Paribas Fortis, Biohub, University, Digital transformation, Ackermans & van Haaren, Committee on European Affairs and Oversight of the European Funds, Student, List of life sciences, Public, History, Intellectual property, European Investment Fund, Industry, Development, PMV, EIF, Rabies, Investment, KU, European Commission Investment Plan for Europe, EFSI, Growth, Health, Venture, Thuja, Cornerstone, Doctor of Philosophy, Heart, Infection, Real estate, IPO, Physician, Alexander von Humboldt German International School Montreal, Union, Health care, Climate, VIB, Communications satellite, Financial services, Pharmaceutical industry, European

Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs linked to Belgium-based university KU Leuven.

Key Points: 
  • Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs linked to Belgium-based university KU Leuven.
  • Leuven, Belgium, 25 August 2022 Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of KU Leuven spin-offs.
  • The company will also continue to build its highly innovative, first-in-class plug-and-play vaccine platform based on the ground-breaking work of co-founders Professor Johan Neyts and Kai Dallmeier, PhD, from the KU Leuven Rega Institute.
  • From 2005 to 2021, KU Leuven invested 21.7 million in its spin-off companies, and 1.46 billion of external capital was raised.

DGAP-News: DIC Asset AG: Start of construction for “innovation parc”

Retrieved on: 
Wednesday, August 24, 2022
ISIN, Tenant, SDAX, AG, Allianz, Â, Hannover Airport, Pleasure, DIC, Goldbeck, Certification, VIB, Property management, Real estate

DIC Asset AG (DIC), ISIN: DE000A1X3XX4, one of Germanys leading listed property companies, and Bertram Projektmanagement GmbH, a Hanover-based property developer specialising in commercial real estate, jointly laid the foundation stone for their innovation parc development.

Key Points: 
  • DIC Asset AG (DIC), ISIN: DE000A1X3XX4, one of Germanys leading listed property companies, and Bertram Projektmanagement GmbH, a Hanover-based property developer specialising in commercial real estate, jointly laid the foundation stone for their innovation parc development.
  • DIC acquired the new-build logistics development from Bertram Project Management GmbH within the framework of a forward deal.
  • It is also intended to seek its certification under the Gold sustainability standard of the DGNB German Sustainable Building Council.
  • IR/PR Contact DIC Asset AG: